Today, I’m incredibly proud to announce the launch of our first commercial product: ClearStrand-ASD, the first and only objective laboratory test for autism, validated for children as young as 1 month to 36 months old, using just a single strand of hair.
For too long, families have faced exhausting, years-long journeys to secure an autism diagnosis. This is what we aim to change. With ClearStrand-ASD, caregivers and clinicians now have access to an objective, science-backed tool that may help facilitate earlier diagnosis and intervention—at the stage when it matters most.
This milestone wouldn’t have been possible without the dedication of so many. From the incredible researchers and clinicians who spent over 20 years developing this breakthrough with me, to the families and autism specialists who helped us address real needs, to my partners and mentors on the LinusBio board— Ashok Krishnamurthi, Rafi Syed, and Amol Deshpande—and, of course, to my phenomenal team at LinusBio—thank you. You made this happen.
We’re just getting started.
Read our exclusive coverage:
NBC News➡️ https://lnkd.in/gMKVnPsh
Inside Precision Medicine➡️ https://lnkd.in/gWBKzhSX
Visit our website ➡️ https://lnkd.in/gZstP42z